We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Orthopedics Centre of Excellence Planned for Guy’s Hospital

By HospiMedica International staff writers
Posted on 11 Dec 2017
Johnson & Johnson (JNJ; New Brunswick, NJ, USA) Managed Services and Guy's and St. More...
Thomas' NHS Foundation Trust (London, United Kingdom) have entered into a 15-year partnership to deliver an Orthopedics Centre of Excellence.

The new partnership between JNJ Managed Services and Guy’s and St. Thomas’ NHS Foundation Trust is designed to optimize the standard of care for orthopedic patients by addressing challenges facing the NHS highlighted in two recent reports by Lord Carter and Professor Briggs, which attempt to address increasing resource challenges in the United Kingdom, partly due to changing demographics that project that by 2030, there will be around 15 million people in the United Kingdom over the age of 65.

As part of the agreement, the orthopedics center at Guy’s Hospital will be expanded and redeveloped, allowing more patients to have access to services. Plans include the development of an additional operating theatre in year one, and eight new state-of-the-art theatres by the end of year three. JNJ will also streamline the supply chain to procure devices, surgical instruments, and implants needed for orthopedic surgery. The Center of Excellence will also provide a hub for education and training, and offer a dedicated space to facilitate leading-edge research.

“The Johnson & Johnson Managed Services partnership will further increase the time that frontline clinicians can focus on patient care and enable us to identify opportunities to improve the supply chain,” said Peter Earnshaw, clinical director of surgery at Guy’s and St. Thomas’. “Through the development of new operating theatres, it will also increase capacity so that we can treat more patients more quickly and will give our clinical teams opportunities to be at the forefront of new developments in orthopedic care.”

“This latest collaboration is testament to our ongoing commitment to Guy’s and St. Thomas’ NHS Foundation Trust, and our commitment to join forces with health care systems to help them address their most pressing challenges,” said Michelle Brennan, Company Group Chair of JNJ Medical Devices Europe, Middle East, and Africa.

Related Links:
Johnson & Johnson
Guy's and St. Thomas' NHS Foundation Trust

Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Absorbable Monofilament Mesh
Phasix Mesh
New
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: An alternative adhesive for wearable medical devices (Photo courtesy of Rachel Barton/Texas A&M Engineering)

First Of Its Kind Adhesive Offers More Comfortable Alternative for Wearable Medical Devices

Wearable healthcare devices, such as glucose and heart monitors, are widely used because they gather real-time health data to support patient safety. However, they must often be worn on the arms or chest... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.